ArticleFrontiers in oncology2026

Targeting WNK1 suppresses acute myeloid leukemia progression and enhances sensitivity to venetoclax.

Fangli Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.